BioSpace News Archive

New study sheds light on medication administration errors leading to death – omission is a common cause

Medication administration errors leading to death are common with anticoagulants and antibiotics in particular, according to a new study that analysed incidents reported in England and Wales.

December 7, 2018
·
3 min read
Gene-editing a significant leap forward in biomedical research but needs strong legal framework for ethical usage, says GlobalData

Following the recent claims by He Jiankui, a scientist and professor of Biology at the Southern University of Science and Technology in Shenzhen, Guangdong, China, that he has successfully created the world’s first gene-edited babies,

December 7, 2018
·
1 min read
Policy

Syngenta exercises licensing option for enabling technology from Ingenza

Ingenza is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products.

December 7, 2018
·
2 min read
Business

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

iDD biotech reports that it has received a second milestone payment after its partner, Genmab, started a Phase I/IIa trial of GEN1029 (HexaBody-DR5/DR5).

December 7, 2018
·
2 min read
Policy

Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series

Medtronic is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018.

December 7, 2018
·
2 min read
Drug Development

ADC Therapeutics Presents Updated Data from Clinical Trials of Novel Antibody Drug Conjugates

ADCT-402 (loncastuximab tesirine) continues to demonstrate acceptable safety profile and anti-tumor activity in patients with relapsed or refractory diffuse large B-cell lymphoma; data from 183-patient study supports continued evaluation in ongoing pivotal Phase II trial

December 7, 2018
·
8 min read
Policy

Axovant Announces Feedback From FDA Meeting Regarding AXO-Lenti-PD for Parkinson’s Disease and Progress in Ongoing SUNRISE-PD Phase 2 Clinical Trial

Meeting with FDA confirmed that studies previously conducted using first generation ProSavin® may be considered part of a single development program with AXO-Lenti-PD

December 7, 2018
·
7 min read
Drug Development

GENFIT: Positive Phase 2 Results from Study of Elafibranor in Primary Biliary Cholangitis

Elafibranor successfully meets primary endpoint with high statistical significance of p<0.001

December 7, 2018
·
3 min read
Policy

ltragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™ (burosumab injection) for the Treatment of X–linked Hypophosphatemia (XLH) in Adults and Children

First Approved Treatment for XLH in Canada that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease

December 7, 2018
·
9 min read
Business

BIOASTER collaborates with Bio-Rad and Genetic Analysis to develop novel microbiome-based diagnostics within the field of metabolic disorders

Resulting new tests will help researchers investigate links between gut microbiota and diabetes and obesity

December 7, 2018
·
3 min read